What is the translation of " A SECOND STUDY " in Croatian?

• drugom ispitivanju
• drugoj studiji
• drugo ispitivanje

Examples of using A second study in English and their translations into Croatian

A second study on embryo-fetal development in Lister-Hooded rats did not achieve sufficient exposure.
Drugo ispitivanje embrio-fetalnog razvoja u Lister- Hooded štakora nije postiglo dovoljnu izloženost.

Already in our century, following the results of a second study, it turned out that the first place was taken by a special shade.
Već u našem stoljeću, nakon rezultata druge studije, ispostavilo se da je prvo mjesto snimljeno posebnom sjenom zvanom marrs green.

In a second study scientists set out to replicate the previous study in order to verify the results.
U je druga studija znanstvenici postavi ponoviti prethodni studij kako bi provjerili rezultate.

One of the studies involved women weighing 60 kg or less who received a 100-microgram dose of Elonva, and a second study involved women weighing above 60 kg who received a 150-microgram dose.
Jedno od ispitivanja obuhvatilo je žene s tjelesnom težinom od 60 kg ili manje koje su primile dozu od 100 mikrograma lijeka Elonva, dok je drugo ispitivanje obuhvatilo žene tjelesne težine veće od 60 kg koje su primile dozu od 150 mikrograma.

A second study in 280 such patients compared Imbruvica with another cancer medicine, temsirolimus.
U drugom ispitivanju na 280 bolesnika lijek Imbruvica uspoređen je s drugim citostatikom, temsirolimusom.

Doses administered in one study were 0.2 ml above 25 kg body weight and 0.1ml under 25 kg, and in a second study 0.5ml above 20 kg body weight and 0.3 ml under 20 kg, by bolus peripheral intravenous injection followed by a saline flush.
Doze primijenjene u jednom ispitivanju iznosile su 0, 2 ml za ispitanike iznad 25 kg tjelesne težine i 0, 1 ml do 25 kg, a u drugom ispitivanju 0, 5 ml iznad 20 kg tjelesne težine i 0, 3 ml ispod 20 kg, primijenjene u bolusu perifernom intravenskom injekcijom, nakon čega je slijedilo ispiranje fiziološkom otopinom.

A second study was completed in 334 asthmatic children aged 6 to 12 years old of which 53.6% were influenza-positive.
Drugo ispitivanje provedeno je u 334 astmatične djece u dobi od 6 do 12 godina, od kojih je 53, 6% bilo influenca-pozitivno.

These results were replicated in a second study involving 263 Rheumatoid arthritis patients given doses of standardized TGP peony extract.
Ovi rezultati su se preslikavaju u drugoj studiji koja uključuje 263 reumatoidni artritis bolesnika doza standardiziranog TGP božura ekstrakt.

In a second study, ERICA, Ranexa was added to treatment with amlodipine 10 mg once daily the maximum labelled dose.
U drugom istraživanju, ERICA, Ranexa je bila dodatni lijek, uz amlodipin 10 mg jednom dnevno maksimalna doza propisana uputom.

A second study looked at 834 patients with melanoma who received either Keytruda or another medicine, ipilimumab.
Drugo ispitivanje obuhvatilo je 834 bolesnika oboljelih od melanoma koji su primili lijek Keytruda ili drugi lijek, ipilimumab.

A second study compared Numient with another treatment containing levodopa and carbidopa in 393 patients with advanced Parkinson's disease.
Drugo je ispitivanje usporedilo Numient s drugom terapijom koja je sadržavala tvari levodopa i karbidopa.

In a second study, in 14 patients≥ 7 years of age, the results regarding heart rate variability were consistent with previous findings.
U drugom ispitivanju, kod 14 bolesnika ≥ 7 godina, rezultati o varijabilnosti srčane frekvencije bili su dosljedni s prethodnim nalazima.

In a second study, mice were administered zidovudine at doses up to 40 mg/kg for 24 months, with exposure beginning prenatally on gestation day 10.
U drugom ispitivanju su miševima u razdoblju od 24 mjeseca davali zidovudin u dozama do 40 mg/kg, počevši prenatalno od 10. dana gestacije.

In a second study 42 broiler chickens were spray vaccinated at 1 day old and challenged 3 weeks after vaccination with a QX strain of the virus.
U drugom ispitivanju 42 brojler pilića u dobi od 1 dana cijepljena su sprejanjem i izložena su 3 tjedna nakon cijepljenja sojemQX virusa.

In a second study involving 704 patients, Mekinist with dabrafenib was compared with another medicine for melanoma, vemurafenib.
U drugom ispitivanju, kojim je bilo obuhvaćeno 704 bolesnika, uspoređena je kombinacija lijeka Mekinista i dabrafeniba s još jednim lijekom za liječenje melanoma, vemurafenibom.

In a second study, 49 subjects aged 18-60 years received two doses of AS03-adjuvanted vaccine containing 3.75 µg HA derived from A/Indonesia/05/2005 on days 0 and 21.
U drugom ispitivanju, 49 ispitanika u dobi od 18 do 60 godina primilo je dvije dozeAS03- adjuvantiranog cjepiva koje sadrži 3, 75 µg hemaglutinina iz soja A/Indonesia/05/2005 i to 0. te 21. dana.

In a second study, patients with invasive candidiasis received daily doses of caspofungin at 50 mg/day(following a 70-mg loading dose on Day 1) or caspofungin at 150 mg/day see section 4.8.
U drugom ispitivanju bolesnici s invazivnom kandidijazom primali su kaspofungin u dnevnoj dozi od 50 mg/dan(nakon udarne doze od 70 mg 1. dana) ili 150 mg/dan vidjeti dio 4.8.

In a second study published Wednesday in Nature, some of the same scientists offered new projections of how much Antarctica will contribute to sea level rise by 2100- a hotly debated topic.
U drugoj studiji objavljenoj u srijedu u magazinu Nature, neki od ovih istih naučnika ponudili su nove projekcije o tome koliko će Antarktik doprinijeti rastu nivoa mora do 2100. godine.

In a second study, fifteen patients with left ventricular hypertrophy completed a 6 month placebo- controlled study and entered an extension study..
U drugom ispitivanju, 15 bolesnika s hipertrofijom lijevog ventrikula završilo je šestomjesečno placebom kontrolirano kliničko ispitivanje i uključilo se u produžetak ispitivanja..

In a second study, sixty-six ferrets were divided into 6 cohorts of 11 ferrets and were immunized on days 0 and 21 with 3.75 µg or 7.5 µg of the Indonesia vaccine or were sham vaccinated.
U drugom je ispitivanju šezdeset šest tvorova bilo podijeljeno u 6 kohorta po 11 tvorova koji su bili imunizirani 0. i 21. dana s 3, 75 µg ili 7, 5 µg cjepiva Indonesia ili su bili lažno cijepljeni.

In a second study comparing subjects with moderate or severe renal impairment to subjects with normal renal function, sugammadex clearance progressively decreased and t1/2 was progressively prolonged with declining renal function.
U drugom ispitivanju, u kojem su uspoređivani ispitanici s umjerenim ili teškim oštećenjem funkcije bubrega s ispitanicima koji imaju normalnu funkciju bubrega, klirens sugamadeksa progresivno se smanjivao, a t1/2 progresivno produljivao sa smanjenjem funkcije bubrega.

A second study involved 51 children under 12 years of age previously treated with other factor VIII products, who also had 3.8 bleeds per year on average during treatment with Iblias mostly related to injuries.
U drugo ispitivanje bilo je uključeno 51 dijete u dobi ispod 12 godina prethodno liječeno drugim lijekovima koji sadrže faktor VIII, a u kojih je tijekom liječenja lijekom Iblias došlo do krvarenja u prosjeku 3, 8 puta godišnje uglavnom zbog ozljeda.

In a second study in 795 patients with the squamous cell cancer type, patients treated with Giotrif lived on average for 2.6 months without their disease worsening compared with 1.9 months for patients treated with another cancer medicine, erlotinib.
U drugom ispitivanju koje je obuhvatilo 795 bolesnika s rakom skvamoznih stanica bolesnici liječeni lijekom Giotrif živjeli su prosječno 2, 6 mjeseci bez pogoršanja bolesti u usporedbi s 1, 9 mjeseci u bolesnika koji su liječeni drugim lijekom protiv raka, erlotinibom.

In a second study to evaluate the contribution of a CYP1A2 inhibitor alone to metabolism changes, co-administration of fluvoxamine alone with pomalidomide increased mean exposure to pomalidomide by 125% with a 90% confidence interval[98% to 157%] compared to pomalidomide alone.
U drugom ispitivanju, u kojem je procijenjen doprinos samo inhibitora CYP1A2 na promjene metabolizma, istodobna primjena samog fluvoksamina s pomalidomidom povećala je srednju vrijednost izloženosti pomalidomidu za 125% uz 90%-tni interval pouzdanosti[98% do 157%] u usporedbi sa samim pomalidomidom.

A second study involved 23 children aged from just under 2 to nearly 12 years of age, who experienced 26 bleeding episodes during the study: treatment of bleeding episodes was rated as excellent in 50% of cases and good in another 46%, and the average bleeding rate was reduced from 6.8 to 2.7 bleeds per year.
Drugo ispitivanje obuhvatilo je 23 djece u dobi od nepune dvije godine do gotovo 12 godina starosti, koji su iskusili 26 epizoda krvarenja tijekom ispitivanja: terapija epizoda krvarenja ocijenjena je kao odlična u 50% slučajeva i kao dobra u daljnjih 46%, a prosječna stopa krvarenja smanjena je sa 6, 8 na 2, 7 krvarenja godišnje.

After the Vežica Primary School in Rijeka, this is a second study visit within the framework of the"e-Schools" pilot project, and, in addition to in-person meetings, the community of practitioners also exchanges experiences virtually on a daily basis through the Yammer enterprise social network, which accounts for almost 900 messages exchanged monthly in order to advance classes and promote frequent use of technology in learning and teaching.
A studijski posjet završio je okruglim stolom. Nakon riječke Osnovne škole Vežica, ovo je drugi studijski posjet u sklopu pilot projekta„e-Škole“ a uz susrete uživo, zajednica praktičara svakodnevno razmjenjuje iskustva i virtualno u okviru poslovne društvene mreže Yammer preko koje se razmjeni gotovo 900 poruka mjesečno s ciljem unaprjeđivanja nastave i poticanja učestale uporabe tehnologije u učenju i poučavanju.

A second main study looked at the benefits of Akynzeo in patients undergoing moderately emetogenic chemotherapy.
Drugo glavno ispitivanje istražilo je koristi lijeka Akynzeo u bolesnika koje se podvrgavaju umjereno emetogenoj kemoterapiji.

A second field study was conducted in dogs infested with at least three live attached ticks.
Drugo terensko ispitivanje provedeno je u pasa zaraženih s najmanje tri živa primljena krpelja.

In a second 26-week study hyperplasia of transitional cells in the urinary bladder occurred with a much lower incidence.
U drugom 26-tjednom ispitivanju, incidencija hiperplazije prijelaznog epitela u mokraćnom mjehuru bila je puno niža.

In a second main study involving 1,417 patients, patients were given Tecfidera, placebo or another medicine, glatiramer acetate.
U drugom glavnom ispitivanju koje je obuhvatilo 1 417 bolesnika, bolesnici su primili lijek Tecfidera, placebo ili drugi lijek, glatiramer acetat.